What is RMSL's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for RMSL?

P/E (TTM) is n/a and 52-week range is $0.00 to $0.01 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s RMSL figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for RMSL?

The company profile lists revenue (TTM) near $17K, net income (TTM) near $-293M, EPS (TTM) near $-0.00 when available from the market-data feed. Figures are informational and may lag live markets.

Where is REMSleep Holdings Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Clearwater, Florida, US, 1.69B shares outstanding, ISIN US75990A2006 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Free AI scores & summaries library

REMSleep Holdings Inc

$RMSL

Health Care · Health Care Equipment & Supplies

Run Scenarios

$0.00

-6.67%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

RemSleep Holdings, Inc. engages in the design and manufacture of medical devices and products for the treatment of sleep apnea and other respiratory conditions. The company is headquartered in Clearwater, Florida and currently employs 2 full-time employees. The company went IPO on 2008-12-15. The Company’s focus is primarily on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. Its patented DeltaWave product is a nasal-pillow type interface that is designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. DeltaWave delivers comfort and airflow for better sleep and improved CPAP therapy. The Company’s product is manufactured by mold makers. The company has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.

Employees

Website

www.remsleep.com/

IPO

2008-12-15

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)